Skip to main content
British Journal of Pharmacology and Chemotherapy logoLink to British Journal of Pharmacology and Chemotherapy
. 1966 Feb;26(2):322–333. doi: 10.1111/j.1476-5381.1966.tb01911.x

The effect of propranolol on the cardiovascular responses to isoprenaline, adrenaline and noradrenaline in the anaesthetized dog.

R G Shanks
PMCID: PMC1510647  PMID: 5912680

Full text

PDF
322

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. AVIADO D. M., Jr Cardiovascular effects of some commonly used pressor amines. Anesthesiology. 1959 Jan-Feb;20(1):71–97. doi: 10.1097/00000542-195901000-00012. [DOI] [PubMed] [Google Scholar]
  2. AVIADO D. M., Jr, WNUCK A. L. Mechanisms for cardiac slowing by methoxamine. J Pharmacol Exp Ther. 1957 Jan;119(1):99–106. [PubMed] [Google Scholar]
  3. BLACK J. W., CROWTHER A. F., SHANKS R. G., SMITH L. H., DORNHORST A. C. A NEW ADRENERGIC BETARECEPTOR ANTAGONIST. Lancet. 1964 May 16;1(7342):1080–1081. doi: 10.1016/s0140-6736(64)91275-9. [DOI] [PubMed] [Google Scholar]
  4. BLACK J. W., STEPHENSON J. S. Pharmacology of a new adrenergic beta-receptor-blocking compound (Nethalide). Lancet. 1962 Aug 18;2(7251):311–314. doi: 10.1016/s0140-6736(62)90103-4. [DOI] [PubMed] [Google Scholar]
  5. Black J. W., Duncan W. A., Shanks R. G. Comparison of some properties of pronethalol and propranolol. Br J Pharmacol Chemother. 1965 Dec;25(3):577–591. doi: 10.1111/j.1476-5381.1965.tb01782.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. DONALD D. E., KVALE J., SHEPHERD J. T. THE EFFECT OF AN ADRENERGIC BETA-RECEPTOR ANTAGONIST ON THE CARDIOVASCULAR SYSTEM OF THE DOG. J Pharmacol Exp Ther. 1964 Mar;143:344–349. [PubMed] [Google Scholar]
  7. FURCHGOTT R. F. The receptors for epinephrine and norepinephrine (adrenergic receptors). Pharmacol Rev. 1959 Jun;11(2 Pt 2):429–442. [PubMed] [Google Scholar]
  8. GLICK G., BRAUNWALD E. RELATIVE ROLES OF THE SYMPATHETIC AND PARASYMPATHETIC NERVOUS SYSTEMS IN THE REFLEX CONTROL OF HEART RATE. Circ Res. 1965 Apr;16:363–375. doi: 10.1161/01.res.16.4.363. [DOI] [PubMed] [Google Scholar]
  9. GLOVER W. E., GREENFIELD A. D., SHANKS R. G. Effect of dichloroisoprenaline on the peripheral vascular responses to adrenaline in man. Br J Pharmacol Chemother. 1962 Oct;19:235–244. doi: 10.1111/j.1476-5381.1962.tb01185.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. GREEN H. D., KEPCHAR J. H. Control of peripheral resistance in major systemic vascular beds. Physiol Rev. 1959 Jul;39(3):617–686. doi: 10.1152/physrev.1959.39.3.617. [DOI] [PubMed] [Google Scholar]
  11. MAXWELL G. M., ROBERTSON E., ELLIOTT R. B. THE EFFECTS OF A NEW BETA ADRENERGIC BLOCKING AGENT (NETHALIDE; ALDERLIN) UPON THE GENERAL AND CORONARY HAEMODYNAMICS OF THE INTACT ANIMAL. Aust J Exp Biol Med Sci. 1963 Oct;41:511–515. doi: 10.1038/icb.1963.41. [DOI] [PubMed] [Google Scholar]
  12. MORAN N. C., PERKINS M. E. Adrenergic blockade of the mammalian heart by a dichloro analogue of isoproterenol. J Pharmacol Exp Ther. 1958 Nov;124(3):223–237. [PubMed] [Google Scholar]
  13. ORLANS F. B., FINGER K. F., BRODIE B. B. Pharmacological consequences of the selective release of peripheral norepinephrine by syrosingopine (Su 3118). J Pharmacol Exp Ther. 1960 Feb;128:131–139. [PubMed] [Google Scholar]
  14. POWELL C. E., SLATER I. H. Blocking of inhibitory adrenergic receptors by a dichloro analog of isoproterenol. J Pharmacol Exp Ther. 1958 Apr;122(4):480–488. [PubMed] [Google Scholar]
  15. STONE C. A., ROSS C. A., WENGER H. C., LUDDEN C. T., BLESSING J. A., TOTARO J. A., PORTER C. C. Effect of alpha-methyl-3,4-dihydroxyphenylalanine (methyldopa), reserpine and related agents on some vascular responses in the dog. J Pharmacol Exp Ther. 1962 Apr;136:80–88. [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology and Chemotherapy are provided here courtesy of The British Pharmacological Society

RESOURCES